Bryan Wahl, General Counsel at Tarsus Pharmaceuticals, Inc. (TARS), sold 12,440 shares at $69.42 ($850K) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Seasonal sale ($850k) by General Counsel — this insider has traded TARS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.42 | 4,084 | $284K | 33.3% |
| 2 | $68.71 | 4,125 | $283K | 33.3% |
| 3 | $67.00 | 4,231 | $283K | 33.3% |
| Total | $68.36 avg | 12,440 | $850K | 100% |
| Filing → |
| TARS | SELL | 2023-12-01 | $273K | — | Filing → |
| TARS | SELL | 2023-03-23 | $14K | — | Filing → |
| TARS | SELL | 2023-03-21 | $9K | — | Filing → |